- Veri Yok
Türkçe
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Two dimensional transition metal chalcogenides have multi valley structures in their energy bands, giving them electron valley degrees of freedom, making them an ideal platform for studying multi body interactions. As the main mechanism of valley depolarization, the valley scattering process of free electrons or bound excitons is crucial for exploring excited state electron phonon interactions and...
Scientists are exploring new ways to get around limitations on the lithography machines used to produce microchips. Researchers are using particle accelerators to create new laser sources that could lay the foundation for the future of semiconductor manufacturing.Plans are underway to build a particle accelerator with a circumference between 100 and 150 meters (328 and 492 feet), about the size of...
Recently, Opton Laser International, a supplier specializing in photonics, is currently distributing manufacturer UltraFast Innovations (UFI)'s ultra-high contrast third-order autocorrelator Tundra++. The new generation Tundra aims to characterize the temporal intensity distribution and quality of laser pulses with particularly high sensitivity.This is to avoid the harmful effects caused by the hi...
Figure: Experimental setup.Quantum memory that relies on quantum band integration is a key component in developing quantum networks that are compatible with fiber optic communication infrastructure. Quantum engineers and information technology experts have yet to create such a high-capacity network that can form integrated multimode photonic quantum memories in communication frequency ban...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...